J&J’s Janssen to close part of its vaccine division, media reports say
Published
Johnson & Johnson’s JNJ-N Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported. In an e-mailed response on Wednesday, Johnson & Johnson confirmed plans to…
#netherlands #detelegraaf #johnsonjohnson #leiden #dutch #rsv #janssen #fda